People are the cornerstone of our society. Vietnam, with its demographic shifts and societal changes, experiences pressure on its health systems and demands new directions in the delivery of healthcare.
These new directions are pushing companies, hospitals and research institutes to provide innovative solutions for the patients and ensure the demands of the population are met.
This break-out session will look into new developments regarding pharmaceutical and vaccine requirements, the local research and development that this has enabled, and how the hospitals are collaborating with these research institutes.
Agenda:
09.00 – 09.20: Presentation: “Innovation saves lives” By Noel Yeo, CEO of Hanh Phuc Hospital
09.20 – 09.40: Presentation by Professor Sophie Yacoub Head of the Dengue Research Group and Associate OUCRU-Vietnam
09.40 – 10.10: Presentation: “Adult Immunization – One of Innovative Solution” by Dr. Elena DeAngelis, Country Medical Affairs Director of GSK
10.10 – 10.30: Presentation: “Sustainable and Innovative Medical Cold Chain” by Luc Provost, CEO of B-medical systems
10.30 – 10.45 Coffee Break
10.45 – 11.30: Discussion Panel
Break-out room info:
- Location: Blue Room, 1st floor, Pullman Saigon Center, Ho Chi Minh City, Vietnam
- Time: 09.00 – 11.30
- Date: 1 December 2023
Moderator
Evelyne Kestelyn, Secretary-General
BeLuxCham
Evelyne Kestelyn, Secretary-General of BeLuxCham and Head of the Clinical Trials Unit at OUCRU, is a seasoned public health specialist with over 15 years of experience in implementing and overseeing research programs in Low- and Middle-Income Countries (LMICs).
Her expertise spans diverse areas, including contraceptive technologies, HIV prevention, sexually transmitted infections, and clinical trials design and implementation. Evelyne excels in training and coordinating multi-disciplinary, multinational teams, showcasing her commitment to advancing public health initiatives and research in LMICs.
Speakers
Yeo Sheng Ming Noel
Noel Yeo Sheng Ming is a healthcare business leader with nearly two decades of experience. In roles spanning basic to complex healthcare, he’s known for leading large healthcare networks and strategic projects, showcasing proactive and patient leadership. During the recent pandemic, he led IHH Healthcare Singapore’s COVID-19 Coordination Center, earning national recognition for his contributions. With a background in crisis management and business transformation, Noel aims to contribute to Southeast Asia’s healthcare sector through various projects.
Noel holds an MBA, a Directorship Certificate, and a Postgraduate Certificate in Medical Law and Ethics. He actively volunteers for non-profit organizations, including the Central Singapore Community Development Council, the Singapore Cancer Society, and the Singapore Medical Association. Additionally, he is a Certified Information Privacy Professional/Asia by the International Association of Privacy Professionals.
Luc Provost
Luc Provost, the CEO of B Medical Systems and Vice-President at Azenta Life Sciences, is a visionary leader with over 20 years of executive management experience. Committed to innovation and customer-centricity, he has played a pivotal role in B Medical Systems’ success for over 24 years. Since the acquisition by Azenta Life Sciences in October 2022, he has also served as Vice President.
Passionate about saving lives through medical solutions in remote areas, Luc Provost is a renowned speaker and thought leader in medical refrigeration. His impact is evident in B Medical Systems’ revenue growth, global expansions, and the launch of over 50 new products, some setting new WHO PQS standards. His leadership has not only shaped B Medical Systems but has also fostered meaningful collaborations with central governments, health ministries, and international organizations worldwide.
Sophie Yacoub
Dr. Sophie Yacoub, Associate Professor, is the leader of a large-scale research program on dengue fever. She focuses on studying the disease’s mechanisms, precise clinical medical trials, and the use of innovative technologies such as wearable devices, physiological monitoring, and artificial intelligence for medical imaging and clinical decision support systems.
Moreover, she is a Wellcome Clinical Career Development Fellow and a specialist in Infectious Diseases and Internal Medicine. She also holds an honorary advisory position at the London North West University Healthcare NHS Trust in the UK. Under her leadership, the dengue fever research team is exploring the impact of climate change in Southeast Asia through the integration of new digital technologies, remote patient monitoring, and artificial intelligence. The team’s overall goal is to improve clinical outcomes for dengue fever in Vietnam and worldwide.
With her extensive experience and knowledge in the field of health, Sophie Yacoub is the perfect speaker to share innovative ideas and solutions aligned with ESG goals for this sector.